A joint study by the National Pharmaceutical Council and the University of Arizona School of Pharmacy spotlights real-world evidence in the current health care landscape, and how to expand upon its utility going forward.
The research was published in Value in Health, according to NPC.
NPC says the study explored the three following questions:
- How was RWE perceived and used in managed care environments, including pharmacy and therapeutic committee decisions?
- What features of RWE studies, such as the study design, type of analytic methods, population, outcomes and data sources, make certain studies more useful to payers?
- What barriers are associated with the use of RWE studies at the research study, individual evaluator and payer organization level?